Stay updated on ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Sign up to get notified when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.

Latest updates to the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a consolidated Locations section with state entries (Arizona, California, Maryland, Massachusetts), replacing the previous location blocks. Included revision note v3.3.3 and removed the HHS Vulnerability Disclosure link.SummaryDifference0.5%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.2. Removed the older PubMed sourcing note and revision v3.2.0.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the generic government funding/operating status notice from the page; the study details and other content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedNo significant changes detected in core study details or design. The page information remains consistent with the prior version.SummaryDifference0.4%

- Check91 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference3%

- Check98 days agoChange DetectedAdds version v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) plus an older version tag (v3.0.2).SummaryDifference0.3%

Stay in the know with updates to ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.